I attribute our growth and success to our team’s superior commitment to maintaining the highest standard of excellence. We strive to be at the forefront of innovation in our industry, while never losing sight of our patient’s needs.
Philadelphia, Pennsylvania (PRWEB) November 20, 2013
Pentec Health, Inc. announced today that they have ranked number 302 on Deloitte’s Technology Fast 500™. The award is the ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Pentec Health’s operating revenues grew an impressive 284 percent during this period.
Joseph Cosgrove, Pentec’s Chairman, President and CEO, credits geographic expansion and superior products and services with the company’s explosive growth. “We are honored and extremely proud to be ranked in Deloitte’s Technology Fast 500. As always, I attribute our growth and success to our team’s superior commitment to maintaining the highest standard of excellence. We strive to be at the forefront of innovation in our industry, while never losing sight of our patient’s needs. Our growth is a direct result of that.”, said Cosgrove.
“The 2013 Deloitte Technology Fast 500 companies are exemplary cases of those spurring growth in a tough market through innovation,” said Eric Openshaw, vice chairman, Deloitte LLP and U.S. technology, media and telecommunications leader. “This year’s list is a who’s who of companies behind the most exciting and innovative products and services in the technology space. We congratulate the Fast 500 companies and look forward to what they do next.”
“The fastest growing companies in the US are drivers of constant innovation and operate with the agility to stay ahead of a quickly evolving marketplace, and software, biotech/pharma and internet companies continue to be at the forefront,” added James Atwell, national managing partner of the Emerging Growth Company practice, Deloitte Services LP. “The companies excelling in these sectors have a startup mentality that allows them to be nimble and adapt quickly, which is why they consistently lead the list of fast-growing companies each year.”
Overall, 2013 Technology Fast 500™ companies achieved revenue growth ranging from 137 percent to 208,897 percent from 2008 to 2012, with an average growth of 2,600 percent.
About Deloitte’s 2013 Technology Fast 500™
Technology Fast 500, conducted by Deloitte LLP, provides a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies – both public and private - in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2008 to 2012.
In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company's operating revenues. Companies must have base-year operating revenues of at least $50,000 USD or CD, and current-year operating revenues of at least $5 million USD or CD. Additionally, companies must be in business for a minimum of five years, and be headquartered within North America.
About Pentec Health, Inc.
Pentec Health, Inc., is a privately-held national provider of proprietary nutritional infusion therapies for patients suffering from chronic kidney disease and offers specialized pharmacy and nursing services for patients with implanted drug delivery pumps treating severe pain and spasticity. The company is headquartered in suburban Philadelphia and is proud to be celebrating its 30th year in business. The Joint Commission has consistently awarded Pentec with its Gold Seal of Approval for their commitment to providing the highest level of patient safety and patient care for renal nutrition and specialty infusion home care services. For more information, visit http://www.pentechealth.com.